Targeted therapy for metastatic renal cell carcinoma

Metastatic renal cell carcinoma (RCC) has historically been refractory to cytotoxic and hormonal agents; only interleukin 2 and interferon alpha provide response in a minority of patients. We reviewed RCC biology and explored the ways in which this understanding led to development of novel, effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, P H, Chaganti, R S K, Motzer, R J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361211/
https://www.ncbi.nlm.nih.gov/pubmed/16465192
http://dx.doi.org/10.1038/sj.bjc.6602978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361211/
https://www.ncbi.nlm.nih.gov/pubmed/16465192
http://dx.doi.org/10.1038/sj.bjc.6602978

Ejemplares similares